HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Ahmed Sawas Selected Research
Ahmed Sawas Research Topics
Disease
10
Neoplasms (Cancer)
01/2021 - 08/2015
8
Hodgkin Disease (Hodgkin's Disease)
01/2021 - 11/2016
7
Lymphoma (Lymphomas)
03/2024 - 01/2018
4
T-Cell Lymphoma (Lymphoma, T Cell)
03/2024 - 01/2018
4
Peripheral T-Cell Lymphoma (Lymphoma, T Cell, Peripheral)
02/2020 - 08/2015
3
Hematologic Neoplasms (Hematological Malignancy)
01/2021 - 08/2015
2
Non-Hodgkin Lymphoma (Lymphosarcoma)
01/2021 - 01/2017
2
Exanthema (Rash)
01/2020 - 01/2018
2
Thrombocytopenia (Thrombopenia)
01/2020 - 01/2019
2
Neutropenia
01/2020 - 01/2018
2
Sepsis (Septicemia)
01/2018 - 03/2008
1
Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2024
1
Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse)
01/2021
1
Ataxia Telangiectasia (Louis Bar Syndrome)
09/2020
1
Multiple Myeloma
01/2020
1
Myelodysplastic Syndromes (Myelodysplastic Syndrome)
01/2020
1
Mantle-Cell Lymphoma (Lymphoma, Mantle Cell)
01/2020
1
Waldenstrom Macroglobulinemia (Macroglobulinemia)
01/2020
1
Fatigue
01/2020
1
Adult T-Cell Leukemia-Lymphoma (Leukemia Lymphoma, T Cell, Acute, HTLV I Associated)
01/2019
1
Stomatitis
01/2018
1
Residual Neoplasm
01/2016
1
Drug-Related Side Effects and Adverse Reactions
08/2015
1
Cutaneous T-Cell Lymphoma (Lymphoma, T Cell, Cutaneous)
08/2015
1
Septic Shock (Toxic Shock Syndrome)
03/2008
Drug/Important Bio-Agent (IBA)
6
Brentuximab Vedotin
IBA
12/2020 - 11/2016
5
Bendamustine Hydrochloride
FDA Link
12/2020 - 01/2018
4
romidepsin (FK228)
FDA Link
03/2024 - 01/2018
4
Histone Deacetylase Inhibitors
IBA
03/2024 - 08/2015
3
10-propargyl-10-deazaaminopterin
FDA Link
03/2024 - 11/2017
2
Rituximab (Mabthera)
FDA Link
01/2021 - 01/2017
2
belinostat
IBA
01/2020 - 08/2015
2
Monoclonal Antibodies
IBA
01/2019 - 01/2017
1
Folic Acid Antagonists
IBA
03/2024
1
Drug Combinations
IBA
01/2021
1
TTI-621
IBA
01/2021
1
ricolinostat
IBA
01/2021
1
Nivolumab
IBA
01/2021
1
2- (2,6- dimethylmorpholin- 4- yl)- N- (5- (6- morpholin- 4- yl- 4- oxo- 4H- pyran- 2- yl)- 9H- thioxanthen- 2- yl)acetamide
IBA
09/2020
1
Lenalidomide (CC 5013)
FDA Link
01/2020
1
Aspartate Aminotransferases (Aspartate Transaminase)
IBA
01/2020
1
Alanine Transaminase (SGPT)
IBA
01/2020
1
Creatinine
IBA
01/2020
1
Chimeric Antigen Receptors
IBA
01/2020
1
Azacitidine (5 Azacytidine)
FDA Link
10/2019
1
mogamulizumab
IBA
01/2019
1
CC Chemokines
IBA
01/2019
1
Proteins (Proteins, Gene)
FDA Link
01/2019
1
Immunoconjugates (Immunoconjugate)
IBA
12/2018
1
ublituximab
IBA
01/2017
1
Immune Checkpoint Inhibitors
IBA
11/2016
1
Histone Deacetylases (Histone Deacetylase)
IBA
08/2015
1
Brain Natriuretic Peptide (Natrecor)
FDA Link
03/2008
1
Cytokines
IBA
03/2008
1
Biomarkers (Surrogate Marker)
IBA
03/2008
Therapy/Procedure
7
Drug Therapy (Chemotherapy)
01/2024 - 01/2018
3
Therapeutics
02/2020 - 01/2016
2
Stem Cell Transplantation
01/2018 - 11/2016
1
Aftercare (After-Treatment)
02/2020
1
Salvage Therapy
01/2020